Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Kath
    Member
    • Nov 2010
    • 24

    SOLiD paired end data and BWA - cleaning/mapping

    Hello everyone,

    I notice there has been the odd post about this general topic before but I am still confused!

    I have SOLiD single and paired end data which I would like to take through the following steps:
    1) Quality assessment - Fastqc
    2) Data cleaning - Quality trimming/removing adapters if necessary
    3) Mapping using BWA

    At the moment I am converting the csfasta and qual files in to double-encoded (fakespace) fastq files for BWA. I reverse the F5 reads so BWA treats them correctly. However, can the same fastq files be used with Fastqc? Also, can CutAdapt and fastq_quality_trimmer handle this format? If anyone else out there still uses SOLiD data and can give me some details of their workflows I would be very grateful.

    Best wishes,
    Kath
  • BrianJames
    Member
    • May 2010
    • 13

    #2
    I used to work with SOLiD data, and I have to ask why you are going to all of this trouble. In my experience, the best way to map SOLiD data is to stay in colorspace, and use Bfast, or mapreads (part of lifescope/bioscope).


    Brian

    Comment

    • Kath
      Member
      • Nov 2010
      • 24

      #3
      Thanks for your reply. I have Lifescope mapped BAM files but I'm trying to dedup using Picard and am getting some very high duplication rates. I've been told that Picard seems to overestimate duplication rates in Lifescope mapped data and that BWA provides better compatibility with Picard. I did look into using Bfast but previous benchmarking studies suggested BWA would be better.

      Anyway, it looks like there is a script - solid-trimmer.py - that will do what I want.

      Comment

      • BrianJames
        Member
        • May 2010
        • 13

        #4
        OK. Are you working with DNA-seq, or RNA-seq? If it is DNA seq, I would be worried about not working in colorspace, if it is RNA-seq, removing duplicates from SOLiD short read data may not be a good idea. Just my experience.

        Brian

        Comment

        • colindaven
          Senior Member
          • Oct 2008
          • 417

          #5
          We tested all SOLiD mappers very thoroughly, and NovoalignCS (commercial but not too expensive) won hands-down. I would really recommend it.

          BWA dropped color space support a long time ago and did not perform very well in terms of # mapped reads. Bfast wasn't much fun either.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          210 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          78 views
          0 reactions
          Last Post SEQadmin2  
          Working...